Investigational new drugAndrogen Modulator
Compound 61654
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061654
Risk Class
MODERATE
Last Audit
May 27, 2108
Research Abstract
Androgen Modulator candidate engineered for cellular repair initiatives with automated dossier coverage.
Compound 61654 is a androgen modulator asset inside androgen modulator innovation track initiatives, optimized for cellular repair and tissue regeneration.
The dossier currently sits in investigational new drug with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061654 with updates logged 2108-05-27.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cellular repairTissue regeneration
Nomenclature
CX-61654Androgen Modulator Program 61654
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061654
- [2] Operations Pulse • Androgen Modulator innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61654